We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSOP.L Regulatory News (SOP)

  • There is currently no data for SOP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Spinnaker Business Strategy and Appointments

18 Sep 2018 07:00

RNS Number : 0384B
Spinnaker Opportunities PLC
18 September 2018
 

18 September 2018

 

Spinnaker Opportunities Plc

("Spinnaker" or "the Company")

 

Business Strategy and Appointments of Director and Strategic Consultant

 

Spinnaker Opportunities Plc (LON: SOP), the standard listed cash shell established to make a material acquisition in the energy or industrial sectors is pleased to make three key announcements:

 

· An enlarged strategic focus to include analysis of opportunities in the cannabis processing industry;

· The appointment of Alan Hume as a Director

· The appointment of Peterhouse Capital as Strategic Consultant to the Company, effective immediately

 

Strategic Focus

 

Following a period of intensive discussions with key stakeholders, regulators and other interested parties, the Board of Directors has resolved to enlarge the investment focus of the Company to include, in addition to the energy and industrial sectors, an analysis of investment opportunities in the cannabis processing industry.

 

The Directors are confident that there are numerous attractive, near term investment opportunities within both private and public businesses that undertake legal cannabis processing in jurisdictions that are internationally recognised as having well-developed and reputable laws and regulations that govern this sector.

 

It was stated in the Interim Results statement issued on September 5, that the Company is currently engaged in due diligence of a high graded opportunity in a topical sector. The Company can confirm that this opportunity, which is one of several that the Company is evaluating, involves the extraction and wholesaling of high purity Cannabidiol (CBD) oils from industrial hemp for clients in non-medicinal health and well-ness businesses.

 

At this stage, there can be no assurance that this opportunity, or any that the Company is currently evaluating, will lead to any transaction, but in any event, together with Peterhouse Capital and other stakeholders of the Company, the Directors are motivated and committed to concluding a suitable acquisition against the background of this extended investment horizon.

 

Appointment of Director

 

Alan Hume, a Fellow of Chartered Institute of Management Accountants, is appointed a Director of the Company with immediate effect.

 

Mr Hume has been working with the company as an advisor to the Board since admission in May 2017. Together with the Directors, he has been closely engaged with the due diligence mentioned above and the Company now has a considerable body of relevant expertise. 

 

Before joining Spinnaker, Mr Hume has held the position of Chief Financial Officer at several companies and has served on the Boards of two companies listed on the London Stock Exchange as well as holding senior positions in a number of private companies.

 

One other current directorship is held by Mr Hume with Pharis Energy Ltd. He has held this position since June 2018. The only other directorship held in the last five years was with London Green (194-199) Management Ltd. Mr Hume resigned from this position in May 2016. These companies are currently private, as they were at the time of Mr Hume's engagement.

 

Mr Hume holds 400,000 shares in the Company representing approximately 1.4% of the issued capital. Following his appointment, the total holdings of Directors will be 7,600,120 shares, representing approximately 25.9% of the issued share capital.

 

Appointment of Strategic Consultant

 

Peterhouse Capital have been appointed as Strategic Consultant to the Company, effective immediately.

 

Summarising developments, Andy Morrison, Chairman of Spinnaker stated:

 

"I am pleased to welcome Alan Hume to our Board. His experience of London markets as well as the knowledge of the legal, regulatory and financial aspects of the cannabis processing industry is particularly helpful to the Board. Alan's knowledge complements our existing expertise in the commercial and technical aspects of speciality chemical processing and the business of bringing companies to the public market.

 

"I am also delighted to be working with Peterhouse Capital who have established a leading advisory and capital raising position for cannabis-related quoted stocks in London. They are well placed to help the Company secure a transaction and develop a business of true value and return to investors."

 

 

Enquiries

 

Spinnaker Opportunities Plc

Contact through Blytheweigh (see below)

Andy Morrison / Alan Hume

 

Peterhouse Capital (Strategic Consultant)

Tel: +44 (0)20 7469 0930

Guy Miller / Martin Lampshire

 

SI Capital (Joint Broker)

Tel: +44 (0)1483 413 500

Nick Emerson / Greg Mahoney

 

Blytheweigh (Financial PR)

Tel: +44 (0)20 7138 3204

Tim Blythe / Julia Tilley / Simon Woods

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFKODKFBKDKCD
12
Date   Source Headline
15th Feb 202111:51 amRNSResult of General Meeting
11th Feb 20219:14 amRNSChange of Name
9th Feb 20212:38 pmRNSUpdate on Medicinal Cannabis RTO
29th Jan 202112:07 pmRNSPublication of Prospectus & General Meeting
11th Jan 20211:52 pmRNSUpdate on Proposed Medicinal Cannabis RTO
18th Dec 20207:00 amRNSUpdate on Proposed Medicinal Cannabis RTO
21st Sep 20207:00 amRNSUpdate on Medicinal Cannabis RTO
30th Jul 20207:00 amRNSHalf Yearly Report (Unaudited)
30th Jun 20207:00 amRNSAnnual General Meeting Q&A Document
29th Jun 20201:09 pmRNSResults of Annual General Meeting
17th Jun 20207:00 amRNSUpdate on Medicinal Cannabis RTO
15th Jun 20207:00 amRNSOption Award and Warrants Update
3rd Jun 20204:30 pmRNSNotice of AGM
6th Apr 20203:21 pmRNSAdditional Subscription
25th Mar 202012:59 pmRNSExpiry of Investment Commitment
19th Mar 202011:17 amRNSSubscription and Update on Medicinal Cannabis RTO
11th Mar 20207:00 amRNSResults for the Year Ended 31 December 2019
10th Feb 20207:00 amRNSUpdate on Medicinal Cannabis RTO
21st Jan 202012:37 pmRNSUpdate on Medicinal Cannabis RTO
2nd Dec 201911:30 amRNSUpdate on Proposed Medicinal Cannabis RTO
25th Jul 20197:00 amRNSInterim Results For Period Ended 30 June 2019
19th Jul 20197:00 amRNSConditional Fundraise and Update on RTO
27th Jun 20197:00 amRNSResults of Annual General Meeting
4th Jun 20194:30 pmRNSNotice of AGM
23rd May 20197:48 amRNSNew Locations on BigDish - Replacement
23rd May 20197:00 amRNSNew Locations on BigDish
30th Apr 20197:00 amRNSAnnual Financial Report
27th Feb 201912:45 pmRNSProposed RTO and Suspension of Listing Correction
27th Feb 20199:02 amRNSProposed RTO and Suspension of Listing
8th Feb 201911:13 amRNSTR-1: Notification of major holdings
17th Dec 20185:01 pmRNSChange of Registered Office, Auditor Appointment
6th Dec 20187:00 amRNSDirectorate, Advisory and Business Update
25th Oct 20188:42 amRNSTR1
15th Oct 20187:30 amRNSAdviser/Broker Appointment and Secondary Placing
15th Oct 20187:00 amRNSBoard Changes and Business Update
9th Oct 20183:29 pmRNSTR-1
27th Sep 20188:30 amRNSQ&A - Focus on Cannabis Processing Industry
18th Sep 20187:00 amRNSSpinnaker Business Strategy and Appointments
5th Sep 201812:37 pmRNSHalf Yearly Report for the Period Ended 30 June 18
20th Aug 201811:18 amRNSTR-1
5th Jun 20183:28 pmRNSResult of 2018 Annual General Meeting
2nd May 20182:15 pmRNSKey Information Document
27th Apr 20187:00 amRNSPosting of Report & Accounts and Notice of AGM
16th Apr 20187:25 amRNSResults for the Year Ended 31 December 2017
7th Feb 20183:47 pmRNSIssued Share Capital
22nd Jan 201811:20 amRNSTR-1
19th Jan 201812:11 pmRNSTR-1
16th Jan 20187:00 amRNSAppointment of Retained Advisor
3rd Jan 20181:00 pmRNSCompletion of Placing and Subscription
19th Dec 20177:00 amRNSSubscription and Appointment of Joint Broker
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.